miércoles, 24 de julio de 2013

NOVARTIS´s sale.../ De rebajas: Vasella se va con solo $5.2 million pero...

Pharmaceutical firm Novartis has reached a final pay-off accord with former CEO Daniel Vasella worth CHF4.9 million ($5.2 million). This follows a controversial CHF72 million golden gag – later withdrawn in February – to keep him away from rivals. 

According to the board of directors of the Basel-based pharma giant, Vasella will receive $5.2 million in cash and unrestricted shares for eight months’ work this year assisting with the transition to his successor. 

 He will also get a guaranteed minimum fee of $250,000 a year from 2014 through 2016 just to be available for consulting and coaching. In addition he will be paid a consulting rate of $25,000 a day. 

 This replaces a previous plan to pay Vasella CHF72 million to keep him from working for rivals after he stepped down as chairman on February 22. The Swiss public's outcry led Vasella, who now reportedly lives in the United States and is on the boards of PepsiCo and American Express, to decline the huge severance package. 

Dominique Biedermann, director of the Ethos Foundation which advocates for tempering executive compensation, says the compensation plan announced Wednesday is still "exaggerated" and that "three years is a long time" to transition Vasella out of his position at Novartis. (Ver)

Publicar un comentario